CL2008001073A1 - Use of a nucleic acid sequence encoding a tdr4 homolog to obtain a plant tissue with altered content of a flavonoid component. - Google Patents

Use of a nucleic acid sequence encoding a tdr4 homolog to obtain a plant tissue with altered content of a flavonoid component.

Info

Publication number
CL2008001073A1
CL2008001073A1 CL2008001073A CL2008001073A CL2008001073A1 CL 2008001073 A1 CL2008001073 A1 CL 2008001073A1 CL 2008001073 A CL2008001073 A CL 2008001073A CL 2008001073 A CL2008001073 A CL 2008001073A CL 2008001073 A1 CL2008001073 A1 CL 2008001073A1
Authority
CL
Chile
Prior art keywords
tdr4
homolog
nucleic acid
acid sequence
sequence encoding
Prior art date
Application number
CL2008001073A
Other languages
Spanish (es)
Inventor
Mervin Cecil Poole
Graham Barron Seymour
Helen Elizabeth Cameron Thomson
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of CL2008001073A1 publication Critical patent/CL2008001073A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis

Abstract

Uso de una secuencia de ácido nucleico que codifica para un homólogo tdr4 para obtener un tejido vegetal con contenido alterado, preferiblemente aumentado de un componente flavonoide.Use of a nucleic acid sequence encoding a tdr4 homolog to obtain a plant tissue with altered content, preferably increased content of a flavonoid component.

CL2008001073A 2007-04-16 2008-04-15 Use of a nucleic acid sequence encoding a tdr4 homolog to obtain a plant tissue with altered content of a flavonoid component. CL2008001073A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07106246 2007-04-16

Publications (1)

Publication Number Publication Date
CL2008001073A1 true CL2008001073A1 (en) 2009-01-16

Family

ID=38477341

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001073A CL2008001073A1 (en) 2007-04-16 2008-04-15 Use of a nucleic acid sequence encoding a tdr4 homolog to obtain a plant tissue with altered content of a flavonoid component.

Country Status (3)

Country Link
AR (1) AR066068A1 (en)
CL (1) CL2008001073A1 (en)
WO (1) WO2008125433A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120315332A1 (en) * 2009-12-28 2012-12-13 Peixue Ling Pharmaceutical composition including sunflower extract, preparative method and use thereof
CN105900835A (en) * 2016-04-14 2016-08-31 贵州省亚热带作物研究所 Method for induction of embryogenic callus with pitaya anther
CN109699498B (en) * 2019-03-11 2021-09-03 成都大学 Rhododendron callus culture method
CN110951763B (en) * 2019-11-25 2021-11-30 中国热带农业科学院热带生物技术研究所 Potato Yvirus induced gene silencing system and application thereof
CN112931222A (en) * 2021-04-14 2021-06-11 苏州回文生物种业科技有限公司 Subculture method for tsugeki tissue culture seedlings

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030041356A1 (en) * 2001-03-27 2003-02-27 Lynne Reuber Methods for modifying flowering phenotypes
WO2007028165A2 (en) * 2005-08-31 2007-03-08 Mendel Biotechnology, Inc. Stress tolerance in plants
AU5931300A (en) * 1999-07-12 2001-01-30 Cornell Research Foundation Inc. Ringene compositions and methods for use thereof
ATE539158T1 (en) * 2002-09-18 2012-01-15 Mendel Biotechnology Inc POLYNUCLEOTIDES AND POLYPEPTIDES IN PLANTS

Also Published As

Publication number Publication date
AR066068A1 (en) 2009-07-22
WO2008125433A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
AR092487A2 (en) ANTIBODIES AGAINST 2 HUMAN ANGIOPOYETINE
CL2012000258A1 (en) Process for the preparation of a sprayable hydraulic binder composition that contains as main components water, aggregates, hydraulic binder, setting accelerator, sprayable hydraulic binder; composition; and use
BRPI0921995A2 (en) process of displacement of gas to water, and use of an adsorbent.
GT201400136A (en) COMPOUNDS AND METHODS OF BENZALDEHYDE SUBSTITUTED FOR USE IN INCREASING OXYGENATION OF FABRICS
CR11746A (en) CONDENSED CYCLOPENTANOCARBOXYLIC ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND ITS USE AS PHARMACEUTICAL PRODUCTS
CR11731A (en) COMPOSITIONS AND PROCEDURES FOR PREPARATION AND USE
CL2011002041A1 (en) Compounds derived from 4-isopropylphenylglucitol, sglt1 inhibitors; pharmaceutical preparation; and its use as an agent to improve postprandial hyperglycemia and as a prophylactic or therapeutic agent for diabetes.
BRPI0921802A8 (en) use of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor, as well as a pharmaceutical composition and combination comprising them.
CO6720961A2 (en) Imidazopyridazines substituted
BRPI1009981A2 (en) systems, methods and compositions for optimizing tissue and cell enriched grafts
HN2010000084A (en) SULFONAMIDE DERIVATIVES
BRPI1010775A2 (en) composition, method for preparing a composition, and use of a composition.
BRPI1011886A2 (en) solution containing hypochlorous acid and methods for its use.
CL2012000921A1 (en) Compounds derived from spiropiperidine-methylbenzyloxyphenyl, activators of the rpg-40 receptor; pharmaceutical composition comprising them; and use of the compound to treat diabetes.
CL2012000590A1 (en) Process to prepare w-transaminase (r) -selective.
CL2007002971A1 (en) COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS.
CL2013002123A1 (en) Herbicidal composition comprising topramezone and pinoxaden; use of said composition to control undesirable vegetation; undesirable formulation
CL2008002537A1 (en) Compounds derived from 6-phenyl-nicotinic acid, with ppar-alpha modulating activity; preparation procedure; pharmaceutical composition comprising them; and its use to treat and / or prevent dyslipidemias, arteriosclerosis and heart failure.
BR112012032008A2 (en) s100a4 antibodies and therapeutic uses thereof
CL2009001298A1 (en) Compounds derived from n-cyclohexyl-2-phenoxynicotinamide; pharmaceutical composition comprising them; pharmaceutical combination comprising them; and its use to treat a disease mediated by pde4.
CL2013000734A1 (en) Use of a composition comprising compounds derived from substituted 1-h-imidazol-4-yl to lower intraocular pressure; Pharmaceutical kit
CL2007002970A1 (en) COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS.
CL2012003487A1 (en) Oral pharmaceutical composition comprising a compound derived from quinqzoline and alginic acid or sio2 as an acidic additive.
BRPI0923291A2 (en) process for the distillation of an aqueous polymethylol mixture, composition, and use of a polymethylol.
CL2007002862A1 (en) USE OF THE EPIDERMIC GROWTH FACTOR (EGF) TO TREAT SENSITIVE-MOTOR, PAINFUL NEUROPATHY AND MANIFESTATIONS OF ISCHEMICAL NEURITIS; PHARMACEUTICAL COMPOSITION INCLUDED BY EGF; AND USE OF THE COMPOSITION BEFORE SUCH.